Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study

The glucagon-like peptide-1 receptor agonist (GLP-1RA) dulaglutide has been shown to improve body weight and glycemic control and reduce major cardiovascular (CV) events. In Japan, dulaglutide is used at a fixed dose of 0.75 mg, which is lower than that in Europe and North America. However, the repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsuyama, Hisayuki, Hakoshima, Mariko, Umeyama, Shohei, Iida, Sakura, Adachi, Hiroki, Yanai, Hidekatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046001/
https://www.ncbi.nlm.nih.gov/pubmed/36979848
http://dx.doi.org/10.3390/biomedicines11030869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046001/
https://www.ncbi.nlm.nih.gov/pubmed/36979848
http://dx.doi.org/10.3390/biomedicines11030869

Ejemplares similares